US 9688616
Neprilysin inhibitors
granted A61KA61K31/192A61K31/197
Quick answer
US patent 9688616 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/192, A61K31/197, A61K31/341, A61K31/397